HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Puri, S. K. Articles by Dutta, G. P. Search for Related Content PubMed PubMed Citation Articles by Puri, S. K. Articles by Dutta, G. P.

Methemoglobin Toxicity and Hematological Studies on Malaria Anti-Relapse Compound CDRI 80/53 in Dogs

Methemoglobin toxicities of primaquine and compound N¹-(3-acetyl-4-5-dihydro-2-furanyl)-N⁴-(6-methoxy-8-quinolinyl) 1, 4-pentanediamine, CDRI Code 80/53, have been compared in beagles. Primaquine administration at 3 mg/kg for 7 days produced significantly high (P < 0.001) methemoglobinemia and the levels increased 10.55-fold. Compound 80/53 at 3.75 mg/kg x 7 days produced a marginal increase in methemoglobinemia (3.24-fold; P < 0.02). The methemoglobin formed by primaquine administration was 3.65-fold (P < 0.001) higher than that formed after administration of compound 80/53. There was no significant change in other hematological parameters and liver function tests.